These are the results of a new international trial presented at the “Osteoarthritis, Arthritis and Healthy Aging” symposium held at Aragon’s CIBA.The combination of chondroitin sulfate and glucosamine reduces significantly pain and improves joint mobility.Osteoarthritis is the most prevalent rheumatic disease in Aragon, with 16 percent of the population suffering from this condition.
Like last year, Bioibericas Palafolls factory held a technical seminar in November on the use of its Terra-Sorb products in Eastern Europe.
This is the most important conclusion drawn from the post-hoc analysis of the MOVES clinical trial which was presented today at the annual meeting of the American Academy of Rheumatology.
Bioiberica presented their products for crop quality improvement and environmentally-friendly crop protection